| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/CLC.4960131313 |
| P698 | PubMed publication ID | 2182243 |
| P2093 | author name string | Yusuf S | |
| P2860 | cites work | Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase | Q33447121 |
| Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction | Q35705733 | ||
| Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage | Q44289059 | ||
| Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction | Q49171664 | ||
| Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. | Q54135542 | ||
| Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction | Q69172782 | ||
| Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction | Q69183950 | ||
| Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 | ||
| Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy | Q69406329 | ||
| Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction | Q69872060 | ||
| Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials | Q69908517 | ||
| Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty | Q69912387 | ||
| A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty | Q70041641 | ||
| Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS) | Q70196897 | ||
| The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 | ||
| Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator | Q70388870 | ||
| P921 | main subject | myocardial infarction | Q12152 |
| thrombolysis | Q1931577 | ||
| P304 | page(s) | V53-61; discussion V67-72 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Expanding indications for the use of thrombolytic agents in acute myocardial infarction | |
| P478 | volume | Suppl 5 |
Search more.